Loading...

Benchmark Holdings plc

BHCCFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.37
$0.00(0.00%)

Benchmark Holdings plc (BHCCF) Company Profile & Overview

Explore Benchmark Holdings plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Benchmark Holdings plc (BHCCF) Company Profile & Overview

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass/bream, salmon, shrimp, and tilapia breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was founded in 2000 and is headquartered in Sheffield, the United Kingdom.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOTrond Williksen

Contact Information

44 11 4240 9939
4 Park Square, Sheffield, S35 2PH

Company Facts

800 Employees
IPO DateJun 19, 2018
CountryGB
Actively Trading

Frequently Asked Questions

;